5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

Details

Top
Internal ID 47bf179e-e9b9-42cf-97ad-7853b47127b3
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Flavonoid glycosides > Flavonoid O-glycosides > Flavonoid-3-O-glycosides
IUPAC Name 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
SMILES (Canonical) CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O
InChI InChI=1S/C28H32O16/c1-9-18(32)21(35)23(37)27(41-9)40-8-16-19(33)22(36)24(38)28(43-16)44-26-20(34)17-13(31)6-11(29)7-15(17)42-25(26)10-3-4-14(39-2)12(30)5-10/h3-7,9,16,18-19,21-24,27-33,35-38H,8H2,1-2H3/t9-,16+,18-,19+,21+,22-,23+,24+,27+,28-/m0/s1
InChI Key KEIZXGINFPDITQ-GEBJFKNCSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C28H32O16
Molecular Weight 624.50 g/mol
Exact Mass 624.16903493 g/mol
Topological Polar Surface Area (TPSA) 255.00 Ų
XlogP -1.00
Atomic LogP (AlogP) -1.38
H-Bond Acceptor 16
H-Bond Donor 9
Rotatable Bonds 7

Synonyms

Top
5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

2D Structure

Top
2D Structure of 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.4777 47.77%
Caco-2 - 0.9186 91.86%
Blood Brain Barrier - 0.9250 92.50%
Human oral bioavailability - 0.7143 71.43%
Subcellular localzation Mitochondria 0.6902 69.02%
OATP2B1 inhibitior - 0.5758 57.58%
OATP1B1 inhibitior + 0.9132 91.32%
OATP1B3 inhibitior + 0.9479 94.79%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.4905 49.05%
P-glycoprotein inhibitior - 0.6099 60.99%
P-glycoprotein substrate + 0.6934 69.34%
CYP3A4 substrate + 0.6297 62.97%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8527 85.27%
CYP3A4 inhibition - 0.8619 86.19%
CYP2C9 inhibition - 0.9071 90.71%
CYP2C19 inhibition - 0.9025 90.25%
CYP2D6 inhibition - 0.9231 92.31%
CYP1A2 inhibition - 0.9045 90.45%
CYP2C8 inhibition + 0.8777 87.77%
CYP inhibitory promiscuity - 0.6670 66.70%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6995 69.95%
Eye corrosion - 0.9891 98.91%
Eye irritation - 0.9054 90.54%
Skin irritation - 0.8249 82.49%
Skin corrosion - 0.9594 95.94%
Ames mutagenesis - 0.5300 53.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6651 66.51%
Micronuclear + 0.7492 74.92%
Hepatotoxicity - 0.5125 51.25%
skin sensitisation - 0.9436 94.36%
Respiratory toxicity - 0.5333 53.33%
Reproductive toxicity + 0.8111 81.11%
Mitochondrial toxicity - 0.6625 66.25%
Nephrotoxicity - 0.9033 90.33%
Acute Oral Toxicity (c) III 0.6904 69.04%
Estrogen receptor binding + 0.8250 82.50%
Androgen receptor binding + 0.5280 52.80%
Thyroid receptor binding + 0.5517 55.17%
Glucocorticoid receptor binding + 0.6483 64.83%
Aromatase binding + 0.5833 58.33%
PPAR gamma + 0.6691 66.91%
Honey bee toxicity - 0.7690 76.90%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5849 58.49%
Fish aquatic toxicity + 0.8477 84.77%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.55% 91.11%
CHEMBL1806 P11388 DNA topoisomerase II alpha 97.53% 89.00%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 97.03% 94.00%
CHEMBL2581 P07339 Cathepsin D 96.94% 98.95%
CHEMBL1293249 Q13887 Kruppel-like factor 5 96.90% 86.33%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.87% 96.09%
CHEMBL1951 P21397 Monoamine oxidase A 94.46% 91.49%
CHEMBL3060 Q9Y345 Glycine transporter 2 91.32% 99.17%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 90.58% 85.14%
CHEMBL3401 O75469 Pregnane X receptor 89.23% 94.73%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.07% 95.56%
CHEMBL3194 P02766 Transthyretin 88.07% 90.71%
CHEMBL5339 Q5NUL3 G-protein coupled receptor 120 87.34% 95.78%
CHEMBL2345 P51812 Ribosomal protein S6 kinase alpha 3 84.10% 95.64%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 83.48% 96.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 83.44% 99.15%
CHEMBL1937 Q92769 Histone deacetylase 2 83.05% 94.75%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 82.27% 95.89%
CHEMBL4208 P20618 Proteasome component C5 81.28% 90.00%
CHEMBL4940 P07195 L-lactate dehydrogenase B chain 80.85% 95.53%
CHEMBL4306 P22460 Voltage-gated potassium channel subunit Kv1.5 80.11% 94.03%

Cross-Links

Top
PubChem 5320020
NPASS NPC51604
LOTUS LTS0073565
wikiData Q105139992